Brian Ennis, who has become Chairman of DSG, commented that the shareholders and management of the combined operation are confident that the new structure will bring considerable benefit to both trading entities. "The combined products, experience and investment power of IMS MAXIMS and TAF will allow us to offer a range of financing options to Trusts wishing to use our software. Also, this £9 million investment by DSG has strengthened IMS's balance sheet and will make it possible for us to acquire or enter into appropriate relationships with companies whose products complement ours."
Shane Tickell, CEO of IMS MAXIMS, said: "Being part of the enlarged group will allow IMS MAXIMS to offer finance to new or existing customers. This deal transforms our balance sheet, and leaves us well placed to move forward just at the time when the NHS market is again making independent buying decisions. We have a very satisfied customer base, cutting edge products and now the financial capacity to do business on a large scale, with Trusts as they come to market."
Steve Dartnell CEO of TAF said: "It has always been TAF’s intention to expand in financial services and into the software sector. The creation of DSG and the conclusion of this arrangement with IMS, with whom we have had a good working relationship for a number of years, represents the first significant step in this regard."
About IMS MAXIMS
IMS MAXIMS specialise in developing clinical and administrative software solutions and currently supports more than 100 organisations and 10,000 users of IMS MAXIMS products.
To find out more about IMS MAXIMS and its products visit the website at www.imsmaxims.com.